Back

Prosthesis-Patient Mismatch after Transcatheter or Surgical Treatment of Aortic Valve Stenosis: A Sub-Study of the Randomized DEDICATE-DZHK6 Trial

28 August 2026 (14:45 - 15:00)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Clinical Science: valvular heart disease Aortic Valve Stenosis ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Tobias Rheude

German Heart Center Muenchen Technical University of Munich, Munich (Germany)

4 More presentations in this session

Presentation thumbnail
EuroHeart - TAVI Registry
Professor R. Kharbanda (Oxford, GB)
Slides Video
Presentation thumbnail
Optimal Medical Treatment With or Without Valve Repair in Patients with symptomatic Paradoxical Low-Flow, Low-Gradient Aortic Stenosis: a multicenter, randomized comparison
Professor J. Mehilli (Landshut, DE)
Video
Presentation thumbnail
Efficacy and safety of routine post-dilatation using a balloon-expandable transcatheter aortic valve implantation platform - the randomized controlled DUOTAP trial.
Doctor M. Autherith (Vienna, AT)
Slides Video
Presentation thumbnail
EMPagliflozin after Aortic Valve Replacement study: a randomized clinical trial
Doctor L. Soerensen (Copenhagen, DK)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Clinical Science: valvular heart disease
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 14:45 CET
You may be interested in
thumbnail
Congress Session
Late Breaking Clinical Science: management of aortic stenosis
30 August 2025
thumbnail
Congress Presentation
Prosthesis-patient mismatch is associated with long-term mortality following surgical aortic valve replacement
2 September 2024
thumbnail
Congress Presentation
The impact of prosthesis-patient mismatch on clinical outcomes in patients undergoing transcatheter aortic valve implantation
30 August 2024
thumbnail
Congress Presentation
Association of SGLT2-inhibitor and GLP1-receptor agonist use with clinical outcomes in aortic stenosis: a large-scale propensity-matched study
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources